CD8A and neoplasm: Overall, preclinical and clinical records have suggested that RT recruits DCs and CD8 cells and enhances tumor antigenicity by inducing a burst of gene transcription that is likely to generate many new and potential immunogenic peptides for loading onto MHC-I of both DCs and cancer cells.